Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Fathi

Showing results (21-30 of 206) with videos related to

Pageof 21
Sort By:
British Journal of Haematology|August 4, 2011
Hypereosinophilia in relapsed acute myeloid leukaemiaAnna Colpo, Daniel Boyer, Amir T Fathi
American Journal of Hematology|May 9, 2012
Pure erythroid leukemia evolving from a therapy-related myelodysplastic syndrome secondary to treatment for chronic lymphocytic leukemiaHossein Sadrzadeh, Robert Hasserjian, Amir T Fathi
Discovery Medicine|January 1, 2013
Infectious pathogens and hematologic malignancyHossein Sadrzadeh, Seyed M Abtahi, Amir T Fathi
Cancer Treatment Reviews|January 9, 2010
Exploiting cellular pathways to develop new treatment strategies for AMLAmir T Fathi, Steven Grant, Judith E Karp
Discovery Medicine|December 30, 2011
Molecular alterations underlying eosinophilic and mast cell malignanciesHossein Sadrzadeh, Omar Abdel-Wahab, Amir T Fathi
Therapeutic Advances in Hematology|June 3, 2014
The evolving role of FLT3 inhibitors in acute myeloid leukemia: quizartinib and beyondSeth A Wander, Mark J Levis, Amir T Fathi
Oncotargets and Therapy|June 22, 2018
Reformulating acute myeloid leukemia: liposomal cytarabine and daunorubicin (CPX-351) as an emerging therapy for secondary AMLEvan C Chen, Amir T Fathi, Andrew M Brunner
Protein & Cell|August 29, 2013
The evolving landscape in the therapy of acute myeloid leukemiaGrace L Peloquin, Yi-Bin Chen, Amir T Fathi
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
New molecular abnormalities and clonal architecture in AML: from reciprocal translocations to whole-genome sequencingTimothy A Graubert, Andrew M Brunner, Amir T Fathi
Best Practice & Research. Clinical Haematology|December 6, 2020
A new era of immuno-oncology in acute myeloid leukemia - antibody-based therapies and immune checkpoint inhibitionAnita G Koshy, Naval G Daver, Amir T Fathi
Pageof 21

Showing results (21-30 of 206) with videos related to

Sort By:
Pageof 21
British Journal of Haematology|August 4, 2011
Hypereosinophilia in relapsed acute myeloid leukaemiaAnna Colpo, Daniel Boyer, Amir T Fathi
American Journal of Hematology|May 9, 2012
Pure erythroid leukemia evolving from a therapy-related myelodysplastic syndrome secondary to treatment for chronic lymphocytic leukemiaHossein Sadrzadeh, Robert Hasserjian, Amir T Fathi
Discovery Medicine|January 1, 2013
Infectious pathogens and hematologic malignancyHossein Sadrzadeh, Seyed M Abtahi, Amir T Fathi
Cancer Treatment Reviews|January 9, 2010
Exploiting cellular pathways to develop new treatment strategies for AMLAmir T Fathi, Steven Grant, Judith E Karp
Discovery Medicine|December 30, 2011
Molecular alterations underlying eosinophilic and mast cell malignanciesHossein Sadrzadeh, Omar Abdel-Wahab, Amir T Fathi
Therapeutic Advances in Hematology|June 3, 2014
The evolving role of FLT3 inhibitors in acute myeloid leukemia: quizartinib and beyondSeth A Wander, Mark J Levis, Amir T Fathi
Oncotargets and Therapy|June 22, 2018
Reformulating acute myeloid leukemia: liposomal cytarabine and daunorubicin (CPX-351) as an emerging therapy for secondary AMLEvan C Chen, Amir T Fathi, Andrew M Brunner
Protein & Cell|August 29, 2013
The evolving landscape in the therapy of acute myeloid leukemiaGrace L Peloquin, Yi-Bin Chen, Amir T Fathi
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
New molecular abnormalities and clonal architecture in AML: from reciprocal translocations to whole-genome sequencingTimothy A Graubert, Andrew M Brunner, Amir T Fathi
Best Practice & Research. Clinical Haematology|December 6, 2020
A new era of immuno-oncology in acute myeloid leukemia - antibody-based therapies and immune checkpoint inhibitionAnita G Koshy, Naval G Daver, Amir T Fathi
Pageof 21